期刊文献+

新共识指导下的幽门螺杆菌个体化治疗 被引量:3

Individualized Treatment of Helicobacter pylori Under the Guidance of the New Consensus
原文传递
导出
摘要 目的:分析新共识指导下的幽门螺杆菌个体化治疗。方法:收集近来国内外相关报道也进行分析。结果和结论:根除率逐年下降是当前幽门螺杆菌感染根除治疗面临的棘手问题,第四次全国幽门螺杆菌诊断和治疗的共识已经颁布。在新的共识指导下,强调幽门螺杆菌的个体化治疗是提高幽门螺杆菌根除率的关键。 Objective: To analyzed new consensus on H.pylori eradication and individualized therapy. Methods:we col ected and analyzed related publications.Results and Conclusion:Decreased eradication rate of H.pylori is the thorny issue for the treatment of H.pylori. New consensus for H.pylori eradication has been released. Good strategies for H.pylori eradication are individualized therapy, especial y for patients received the initial treatment.
出处 《临床药物治疗杂志》 2014年第2期7-8,共2页 Clinical Medication Journal
关键词 幽门螺杆菌 个体化治疗 共识 Helicobacterpylori Individualized therapy Consensus
  • 相关文献

参考文献3

二级参考文献22

共引文献1036

同被引文献41

  • 1Enzo Ierardi,Floriana Giorgio,Giuseppe Losurdo,Alfredo Di Leo,Mariabeatrice Principi.How antibiotic resistances could change Helicobacter pylori treatment:A matter of geography?[J].World Journal of Gastroenterology,2013,19(45):8168-8180. 被引量:23
  • 2周丽雅,林三仁,丁士刚,黄雪彪,郭长吉,张莉,崔荣丽,金珠,孟灵梅,张静.根除幽门螺杆菌对胃癌患病率及胃黏膜组织学变化的八年随访研究[J].中华消化杂志,2005,25(6):324-327. 被引量:87
  • 3McColl KE. Clinical practice. Helicobacter pylori infection. N Engl J Med,2010,362 ( 17 ) : 1597 - 1604.
  • 4IARC Working Group on the Evaluation of Carcinogenic Risks to Humans. Infection with Helicobacter pylori. IARC Monogr Eval Carcinog Risks Hum, 1994,61 : 177 - 240.
  • 5Eslick GD, Lim LL, Byles JE, et al. Association of Helicobacter pylori infection with gastric carcinoma: a meta-analysis. Am J Gastroenterol, 1999,94 ( 9 ) :2373 - 2379.
  • 6Malfertheiner P, Megraud F, O' Morain CA, et al. Management of Helicobacter pylori infection -the Maastricht 1V/Florence Consensus Report. Gut,2012,61:646 - 664.
  • 7Liu KS, Hung IF, Seto WK, et al. Ten day sequential versus 10 day modified bismuth quadruple therapy as empirical first line and second line treatment for I~elicobacter pylori in Chinese patients: an open label, randomised, crossover trial. Gut, 2014,63 (9) : 1410 - 1415.
  • 8Ang TL, Fock KM, Song M, et al. Ten-day triple therapy versus sequential therapy versus concomitant therapy as first line treatment for Helicobacter pylori infection. J Gastroenterol Hepatol, 2015,30 (7) :1134 - 1139.
  • 9Zuno A, Hassan C, Ridola L, et al. Standard triple and sequential therapies for Helicobacter pylori eradication: an update. Eur J Intern Med,2013,24(1) :16 - 19.
  • 10Liou JM, Chen CC, Chen MJ, et al. Sequential versus triple therapy for the first-line treatment of Helicobacter pylori: a muhicentre, open-label, randomised trial. Lancet, 2013, 381 (9862) :205 -213.

引证文献3

二级引证文献13

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部